Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Commentary

COMMENTARY: Transcranial Magnetic Stimulation in Multiple Sclerosis: A Method to Improve Movement

Author(s): Francisco J. Medina-Fernandez, Begona M. Escribano and Isaac Tunez

Volume 16, Issue 3, 2017

Page: [218 - 219] Pages: 2

DOI: 10.2174/1871527316666170116161134

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

34

4

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease
Current Drug Delivery

Herpes Simplex Encephalitis: From Virus to Therapy
Infectious Disorders - Drug Targets

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design

Present Drug Therapy of Demyelinating Disorders
Current Drug Therapy

Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors
Medicinal Chemistry

Interplay between Catalysts and Substrates for Activity of Class Ib Aminoacyl-tRNA Synthetases and Implications for Pharmacology
Current Topics in Medicinal Chemistry

Current Treatment of Autoimmune Blistering Diseases
Current Drug Discovery Technologies

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
Current Medicinal Chemistry

White Matter Integrity in Subcortical Vascular Cognitive Impairment: A Multimodal Structural MRI Study
Current Alzheimer Research

Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research

Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology

Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies
Current Medical Imaging

HELLP Syndrome: Pathophysiology and Current Therapies
Current Pharmaceutical Biotechnology

Financial Returns on R&D: Looking Back at History, Looking Forward to Adaptive Licensing
Reviews on Recent Clinical Trials

Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Current Neurovascular Research

Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design

Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued)

Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry

Neuroinflammation in Sepsis: Sepsis Associated Delirium
Cardiovascular & Hematological Disorders-Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy